Miriam Hurst

918 total citations
21 papers, 694 citations indexed

About

Miriam Hurst is a scholar working on Pharmacology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Miriam Hurst has authored 21 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Epidemiology. Recurrent topics in Miriam Hurst's work include Pneumonia and Respiratory Infections (3 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Miriam Hurst is often cited by papers focused on Pneumonia and Respiratory Infections (3 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Miriam Hurst collaborates with scholars based in New Zealand, Australia and United Kingdom. Miriam Hurst's co-authors include Harriet M. Lamb, Stuart Noble, Diana Faulds, Blair Jarvis, Lesley J. Scott, Caroline M. Spencer, David P. Figgitt, Caroline M. Perry, Susan V. Onrust and Douglas Ormrod and has published in prestigious journals such as Drugs, Lara D. Veeken and Clinical & Experimental Immunology.

In The Last Decade

Miriam Hurst

21 papers receiving 640 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Miriam Hurst New Zealand	15	172	126	112	112	94	21	694
Stéphanie Chhun France	14	173 1.0×	194 1.5×	57 0.5×	127 1.1×	109 1.2×	34	792
S. James Matthews United States	14	85 0.5×	84 0.7×	47 0.4×	230 2.1×	127 1.4×	24	674
Guy Aymard France	18	164 1.0×	361 2.9×	120 1.1×	256 2.3×	139 1.5×	35	1.5k
F. FERNÁNDEZ Spain	14	59 0.3×	109 0.9×	130 1.2×	142 1.3×	177 1.9×	48	857
María José García Sánchez Spain	20	245 1.4×	355 2.8×	83 0.7×	235 2.1×	156 1.7×	74	1.2k
Francesco Sbrana Italy	16	119 0.7×	159 1.3×	30 0.3×	196 1.8×	102 1.1×	92	823
M. A. Mangues Spain	20	62 0.4×	72 0.6×	86 0.8×	92 0.8×	226 2.4×	49	1.0k
Peter Matzneller Austria	17	280 1.6×	160 1.3×	57 0.5×	193 1.7×	144 1.5×	49	898
Erik M. van Maarseveen Netherlands	20	138 0.8×	176 1.4×	35 0.3×	101 0.9×	206 2.2×	52	1.2k
Klaus Borner Germany	16	392 2.3×	123 1.0×	50 0.4×	222 2.0×	293 3.1×	33	1.1k

Countries citing papers authored by Miriam Hurst

Since Specialization

Citations

This map shows the geographic impact of Miriam Hurst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miriam Hurst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miriam Hurst more than expected).

Fields of papers citing papers by Miriam Hurst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miriam Hurst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miriam Hurst. The network helps show where Miriam Hurst may publish in the future.

Co-authorship network of co-authors of Miriam Hurst

This figure shows the co-authorship network connecting the top 25 collaborators of Miriam Hurst. A scholar is included among the top collaborators of Miriam Hurst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miriam Hurst. Miriam Hurst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hurst, Miriam, et al.. (2022). Patients with previous immediate hypersensitivity reactions to polyethylene glycol can safely receive the BNT162b2 mRNA COVID‐19 vaccine. Internal Medicine Journal. 52(10). 1818–1820. 3 indexed citations

Ameratunga, Rohan, Andrew Jordan, Alana Cavadino, et al.. (2021). Bronchiectasis is associated with delayed diagnosis and adverse outcomes in the New Zealand Common Variable Immunodeficiency Disorders cohort study. Clinical & Experimental Immunology. 204(3). 352–360. 25 indexed citations

Beasley, Richard, Lutz Beckert, James Fingleton, et al.. (2020). Asthma and Respiratory Foundation NZ Adolescent and Adult Asthma Guidelines 2020: a quick reference guide.. PubMed. 133(1517). 73–99. 19 indexed citations

Bishop, Jonathan, P I Reed, Miriam Hurst, et al.. (2018). Prospective Evaluation of the ESPGHAN Guidelines for Diagnosis of Celiac Disease in New Zealand Children. Journal of Pediatric Gastroenterology and Nutrition. 67(6). 749–754. 19 indexed citations

Chapman, Peter T., et al.. (2012). Comparison of the 2010 American College of Rheumatology/European League Against Rheumatism and the 1987 American Rheumatism Association Classification Criteria for Rheumatoid Arthritis in an Early Arthritis Cohort in New Zealand. The Journal of Rheumatology. 39(11). 2098–2103. 9 indexed citations

Stamp, Lisa K., et al.. (2011). The Christchurch earthquake—providing a rheumatology service during a natural disaster. Clinical Rheumatology. 31(4). 723–725. 3 indexed citations

Kumar, Sunil, et al.. (2006). Life-threatening angioedema in a patient with systemic lupus. Clinical Rheumatology. 25(6). 917–918. 6 indexed citations

Hurst, Miriam & Marianne Empson. (2006). Oral angioedema secondary to ACE inhibitors, a frequently overlooked association: case report and review.. PubMed. 119(1232). U1930–U1930. 7 indexed citations

Hurst, Miriam, Keith M. Hull, Dave Nicholls, & Rohan Ameratunga. (2005). Hereditary Periodic Fever Syndrome Sans Fever or Distinct Periodicity Presenting With Psychosis. JCR Journal of Clinical Rheumatology. 11(6). 329–330. 8 indexed citations

10.

Hurst, Miriam, Harriet M. Lamb, Lesley J. Scott, & David P. Figgitt. (2002). Levofloxacin. Drugs. 62(14). 2127–2167. 90 indexed citations

11.

Perry, Caroline M., Douglas Ormrod, Miriam Hurst, & Susan V. Onrust. (2002). Gatifloxacin. Drugs. 62(1). 169–207. 57 indexed citations

12.

Hurst, Miriam & Blair Jarvis. (2001). Perindopril. Drugs. 61(6). 867–896. 55 indexed citations

13.

Plosker, Greg L. & Miriam Hurst. (2001). Paclitaxel. PharmacoEconomics. 19(11). 1111–1134. 16 indexed citations

14.

Hurst, Miriam & Harriet M. Lamb. (2000). Meropenem. Drugs. 59(3). 653–680. 70 indexed citations

15.

Hurst, Miriam & Caroline M. Spencer. (2000). Ebastine. Drugs. 59(4). 981–1006. 45 indexed citations

16.

Hurst, Miriam & Diana Faulds. (2000). Lopinavir. Drugs. 60(6). 1371–1379. 69 indexed citations

17.

Hurst, Miriam & Stuart Noble. (1999). Stavudine. Drugs. 58(5). 919–949. 50 indexed citations

18.

Hurst, Miriam & Stuart Noble. (1999). Clodronate. Drugs & Aging. 15(2). 143–167. 16 indexed citations

19.

Hurst, Miriam & Stuart Noble. (1999). Zaleplon. CNS Drugs. 11(5). 387–392. 19 indexed citations

20.

D’Cruz, David, Alistair Chesser, M. Comer, et al.. (1995). ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-POSITIVE CRESCENTIC GLOMERULONEPHRITIS ASSOCIATED WITH ANTI-THYROID DRUG TREATMENT. Lara D. Veeken. 34(11). 1090–1091. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact